Literature DB >> 17030627

Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.

Hongkui Zeng1, Alexander Gragerov, John G Hohmann, Maria N Pavlova, Brian A Schimpf, Hui Xu, Long-Jun Wu, Hiroki Toyoda, Ming-Gao Zhao, Alex D Rohde, Galina Gragerova, Rene Onrust, John E Bergmann, Min Zhuo, George A Gaitanaris.   

Abstract

Neuromedin U (NMU) is a highly conserved neuropeptide with a variety of physiological functions mediated by two receptors, peripheral NMUR1 and central nervous system NMUR2. Here we report the generation and phenotypic characterization of mice deficient in the central nervous system receptor NMUR2. We show that behavioral effects, such as suppression of food intake, enhanced pain response, and excessive grooming induced by intracerebroventricular NMU administration were abolished in the NMUR2 knockout (KO) mice, establishing a causal role for NMUR2 in mediating NMU's central effects on these behaviors. In contrast to the NMU peptide-deficient mice, NMUR2 KO mice appeared normal with regard to stress, anxiety, body weight regulation, and food consumption. However, the NMUR2 KO mice showed reduced pain sensitivity in both the hot plate and formalin tests. Furthermore, facilitated excitatory synaptic transmission in spinal dorsal horn neurons, a mechanism by which NMU stimulates pain, did not occur in NMUR2 KO mice. These results provide significant insights into a functional dissection of the differential contribution of peripherally or centrally acting NMU system. They suggest that NMUR2 plays a more significant role in central pain processing than other brain functions including stress/anxiety and regulation of feeding.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030627      PMCID: PMC1698522          DOI: 10.1128/MCB.01148-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice.

Authors:  T J Kowalski; B D Spar; L Markowitz; M Maguire; A Golovko; S Yang; C Farley; J A Cook; G Tetzloff; L Hoos; R A Del Vecchio; T M Kazdoba; M F McCool; J J Hwa; L A Hyde; H Davis; G Vassileva; J A Hedrick; E L Gustafson
Journal:  J Endocrinol       Date:  2005-04       Impact factor: 4.286

2.  Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin.

Authors:  Preeti H Jethwa; Caroline J Small; Kirsty L Smith; Asha Seth; Sarah J Darch; Caroline R Abbott; Kevin G Murphy; Jeannie F Todd; Mohammad A Ghatei; Stephen R Bloom
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-03-22       Impact factor: 4.310

3.  CRF-induced excessive grooming behavior in rats and mice.

Authors:  A J Dunn; C W Berridge; Y I Lai; T L Yachabach
Journal:  Peptides       Date:  1987 Sep-Oct       Impact factor: 3.750

Review 4.  The localization of classical transmitters and neuropeptides within neurons in laminae I-III of the mammalian spinal dorsal horn.

Authors:  A J Todd; R C Spike
Journal:  Prog Neurobiol       Date:  1993-11       Impact factor: 11.685

Review 5.  An ascending general homeostatic afferent pathway originating in lamina I.

Authors:  A D Craig
Journal:  Prog Brain Res       Date:  1996       Impact factor: 2.453

Review 6.  The molecular dynamics of pain control.

Authors:  S P Hunt; P W Mantyh
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

7.  Identification of receptors for neuromedin U and its role in feeding.

Authors:  A D Howard; R Wang; S S Pong; T N Mellin; A Strack; X M Guan; Z Zeng; D L Williams; S D Feighner; C N Nunes; B Murphy; J N Stair; H Yu; Q Jiang; M K Clements; C P Tan; K K McKee; D L Hreniuk; T P McDonald; K R Lynch; J F Evans; C P Austin; C T Caskey; L H Van der Ploeg; Q Liu
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

8.  Hypothalamic actions of neuromedin U.

Authors:  A M Wren; C J Small; C R Abbott; P H Jethwa; A R Kennedy; K G Murphy; S A Stanley; A N Zollner; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  2002-11       Impact factor: 4.736

Review 9.  Neuromedin U and its receptors: structure, function, and physiological roles.

Authors:  Paul J Brighton; Philip G Szekeres; Gary B Willars
Journal:  Pharmacol Rev       Date:  2004-06       Impact factor: 25.468

10.  The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells.

Authors:  Maiko Moriyama; Takahiro Sato; Hiromasa Inoue; Satoru Fukuyama; Hitoshi Teranishi; Kenji Kangawa; Tatsuhiko Kano; Akihiko Yoshimura; Masayasu Kojima
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

View more
  25 in total

Review 1.  Role of G protein-coupled receptors in inflammation.

Authors:  Lei Sun; Richard D Ye
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

2.  Common variants at 5q33.1 predispose to migraine in African-American children.

Authors:  Xiao Chang; Renata Pellegrino; James Garifallou; Michael March; James Snyder; Frank Mentch; Jin Li; Cuiping Hou; Yichuan Liu; Patrick M A Sleiman; Hakon Hakonarson
Journal:  J Med Genet       Date:  2018-09-28       Impact factor: 6.318

3.  Intrathecal neuromedin U induces biphasic effects on sympathetic vasomotor tone, increases respiratory drive and attenuates sympathetic reflexes in rat.

Authors:  A A Rahman; I Z Shahid; P M Pilowsky
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 4.  Neuropeptides controlling energy balance: orexins and neuromedins.

Authors:  Joshua P Nixon; Catherine M Kotz; Colleen M Novak; Charles J Billington; Jennifer A Teske
Journal:  Handb Exp Pharmacol       Date:  2012

Review 5.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

6.  Large-scale, saturating insertional mutagenesis of the mouse genome.

Authors:  Alexander Gragerov; Kyoji Horie; Maria Pavlova; Linda Madisen; Hongkui Zeng; Galina Gragerova; Alex Rhode; Io Dolka; Patricia Roth; Amanda Ebbert; Stephanie Moe; Christopher Navas; Eric Finn; John Bergmann; Demetrios K Vassilatis; George N Pavlakis; George A Gaitanaris
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-24       Impact factor: 11.205

7.  The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).

Authors:  Andrea Peier; Jennifer Kosinski; Kimberly Cox-York; Ying Qian; Kunal Desai; Yue Feng; Prashant Trivedi; Nicholas Hastings; Donald J Marsh
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

8.  A Zebrafish Genetic Screen Identifies Neuromedin U as a Regulator of Sleep/Wake States.

Authors:  Cindy N Chiu; Jason Rihel; Daniel A Lee; Chanpreet Singh; Eric A Mosser; Shijia Chen; Viveca Sapin; Uyen Pham; Jae Engle; Brett J Niles; Christin J Montz; Sridhara Chakravarthy; Steven Zimmerman; Kourosh Salehi-Ashtiani; Marc Vidal; Alexander F Schier; David A Prober
Journal:  Neuron       Date:  2016-02-17       Impact factor: 17.173

9.  Differential effects of selective agonists of neuromedin U1 and U2 receptors in obese and diabetic mice.

Authors:  Hiroaki Nagai; Tomoko Kaisho; Kotaro Yokoyama; Tomoko Asakawa; Hisashi Fujita; Kouta Matsumiya; Jiro Noguchi; Kazue Tsuchimori; Naoki Nishizawa; Yoko Kanematsu-Yamaki; Katsuko Dote; Hiroshi Inooka; Jun-Ichi Sakamoto; Tetsuya Ohtaki; Taiji Asami; Shiro Takekawa
Journal:  Br J Pharmacol       Date:  2017-12-18       Impact factor: 8.739

10.  Appetite-modifying actions of pro-neuromedin U-derived peptides.

Authors:  David A Bechtold; Tina R Ivanov; Simon M Luckman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.